Cite
Pakdaman H, Amini Harandi A, Abbasi M, et al. Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study. Dement Geriatr Cogn Dis Extra. 2017;7(1):136-142doi: 10.1159/000458521.
Pakdaman, H., Amini Harandi, A., Abbasi, M., Delavar Kasmaei, H., Ashrafi, F., Gharagozli, K., Assarzadegan, F., Behnam, B., & Arabahmadi, M. (2017). Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study. Dementia and geriatric cognitive disorders extra, 7(1), 136-142. https://doi.org/10.1159/000458521
Pakdaman, Hossein, et al. "Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study." Dementia and geriatric cognitive disorders extra vol. 7,1 (2017): 136-142. doi: https://doi.org/10.1159/000458521
Pakdaman H, Amini Harandi A, Abbasi M, Delavar Kasmaei H, Ashrafi F, Gharagozli K, Assarzadegan F, Behnam B, Arabahmadi M. Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study. Dement Geriatr Cogn Dis Extra. 2017 May 04;7(1):136-142. doi: 10.1159/000458521. eCollection 2017. PMID: 28626468; PMCID: PMC5471755.
Copy
Download .nbib